Albaniza Alves Tavares

Dr. Albaniza Alves Tavares

orcid

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2025 in Brazilian Journal of Medical and Biological Research
Verified
Journal Article
Open access
PDF file
YGY.V.R. Gomes
Y.V.R. Gomes
Albaniza Alves TavaresAlbaniza Alves Tavares
Albaniza Alves Tavares
RBRossemberg Barbosa
Rossemberg Barbosa
ATA.F. Tomaz
A.F. Tomaz
WSWladymyr B. de Sousa
Wladymyr B. de Sousa
MFMarcus Vinícius Lia Fook
Marcus Vinícius Lia Fook
Biomaterials stimulate diverse biological responses, including inflammation, wound healing, foreign body reactions, and fibrous encapsulation, all critical for evaluating biocompatibility and effectiveness. These responses are influenced by the material's physicochemical and biological properties, such as composition, texture, and surface characteristics. Adverse reactions, such as severe inflammation or fibrous encapsulation, can hinder tissue integration, jeopardizing patient health and increasing healthcare costs. This review aimed to summarize the current scientific evidence on biological responses to biomaterials. A systematic search was conducted through multiple databases (VHL, PubMed, SCOPUS, EMBASE, and Web of Science) including in vitro and in vivo studies that compared biomaterial interactions with the natural immune response (innate and adaptive). From the 791 articles identified, 25 met strict inclusion criteria. These studies revealed variations in immune responses and material surface characteristics, highlighting advancements made to enhance tissue integration. Bioactive materials demonstrated greater potential for tissue regeneration, while inert materials triggered moderate inflammatory reactions. This variability emphasizes the need for a personalized biomaterial selection, considering both short-term biocompatibility and long-term tissue functionality. This review underscores the importance of comprehensive evaluation to optimize biomaterial performance in clinical applications.

1 January 2022 in Research, Society and Development
Verified
Journal Article
Open access
PDF file
Albaniza Alves TavaresAlbaniza Alves Tavares
Albaniza Alves Tavares
Maria Dennise Medeiros MacêdoMaria Dennise Medeiros Macêdo
Maria Dennise Medeiros Macêdo
PLPedro Henrique Correia de Lima
Pedro Henrique Correia de Lima
RBRossemberg Barbosa
Rossemberg Barbosa
WSWladymyr B. de Sousa
Wladymyr B. de Sousa
SSSuedina Maria de Lima Silva
Suedina Maria de Lima Silva
Chitosan/montmorillonite nanocomposite films were prepared by the solvent evaporation method to immobilize the drug ibuprofen (IBU) and delay its release in a medium that simulates the environment of the gastrointestinal tract. The effects of montmorillonite, at different mass proportions (10, 20, and 50%), on the morphological and physical properties of the films were studied. The samples were characterized by X-ray diffraction (XRD), Infrared Spectroscopy (FTIR), Scanning Electron Microscopy (SEM), degree of swelling, drug encapsulation, and drug release efficiency. According to the XRD it was evidenced that the incorporation of montmorillonite to chitosan led to the formation of nanocomposites of ordered morphology. The infrared spectra confirmed the good interaction between montmorillonite and chitosan by the formation of nanocomposites. This fact, which favored the imprisonment of the IBU, reduced the diffusion coefficient in the studied systems. The micrographs comproved the formation of dense and uniform films. The controlled release profile, especially for the nanocomposite with 10% clay mass, showed a slow drug release rate. The incorporation of montmorillonite at different proportions produced different morphologies, with good encapsulation efficiency and an adequate profile for the controlled release of the drug.

1 January 2025 in Materials Research
Verified
Journal Article
Open access
ALAna Diva Sá da Nóbrega Amancio de Lima
Ana Diva Sá da Nóbrega Amancio de Lima
ISIsmael de Assis e Silva
Ismael de Assis e Silva
Albaniza Alves TavaresAlbaniza Alves Tavares
Albaniza Alves Tavares
RBRossemberg Barbosa
Rossemberg Barbosa
JNJoão Emídio da Silva Neto
João Emídio da Silva Neto
MFMarcus Vinícius Lia Fook
Marcus Vinícius Lia Fook
Chitosan/collagen hydrogels have gained prominence in biomedical applications due to their biocompatibility and ability to promote tissue regeneration. However, rheological instability may limit their applicability. This study investigated the structural and rheological properties of chitosan/collagen hydrogels (99:1, 97:3, and 95:5%) crosslinked with 0.1% genipin. The samples were characterized by Fourier Transform Infrared Spectroscopy (FTIR), injectability, viscosity, swelling, biodegradation, and blood clotting time. Genipin crosslinking improved structural stability, increased viscosity and extrusion resistance, and provided slower and more predictable mass loss under physiological and enzymatic conditions. The swelling assay showed a progressive reduction in water uptake with increasing collagen content, further accentuated by genipin, suggesting a denser and more stable polymeric network. Additionally, the hydrogels accelerated blood coagulation, reinforcing their potential use as hemostatic agents.

31 December 2024 in Polymer Composites
Verified
Journal Article
Closed access
CBCristiano José de Farias Braz
Cristiano José de Farias Braz
ADAlisson Rodrigues de Oliveira Dias
Alisson Rodrigues de Oliveira Dias
SFSamuel Nogueira Figueiredo
Samuel Nogueira Figueiredo
ARAna Carolina Ferreira dos Santos Rosa
Ana Carolina Ferreira dos Santos Rosa
IBIagho de Sousa Barros
Iagho de Sousa Barros
RBRenata Barbosa
Renata Barbosa

20 December 2023 in Revista Científica da Escola Estadual de Saúde Pública de Goiás *Cândido Santiago*
Verified
Journal Article
Open access
PDF file
Albaniza Alves TavaresAlbaniza Alves Tavares
Albaniza Alves Tavares
MBMilena C. S. Barbosa
Milena C. S. Barbosa
PSPatrícia Marinho Sampaio
Patrícia Marinho Sampaio
SSSuedina Maria de Lima Silva
Suedina Maria de Lima Silva
MFMarcus Vinícius Lia Fook
Marcus Vinícius Lia Fook
ECErika Barbosa Camargo
Erika Barbosa Camargo
Tratamento: Uso da psilocibina. Indicação: Melhora dos sintomas para ansiedade e depressão. Pergunta: Qual é o efeito do uso da psilocibina em pacientes adultos com diagnóstico confirmado de ansiedade e depressão? Objetivo: Avaliar a segurança e eficácia da psilocibina em pacientes adultos com ansiedade e depressão em comparação com o tratamento com antidepressivos ou em associação com a terapia cognitivo-comportamental (TCC).

Verified
Journal Article
Open access
PDF file
ARAntonio de Aracoeli Lopes Ramalho
Antonio de Aracoeli Lopes Ramalho
Albaniza Alves TavaresAlbaniza Alves Tavares
Albaniza Alves Tavares
Henrique Nunes da SilvaHenrique Nunes da Silva
Henrique Nunes da Silva
RNRomulo Feitosa Navarro
Romulo Feitosa Navarro
VSVicthor Alexandre Vilarins Cardoso da Silva
Victhor Alexandre Vilarins Cardoso da Silva
SSSuedina Maria de Lima Silva
Suedina Maria de Lima Silva
Background/Objectives: Breast implants are widely used in reconstructive surgeries, as well as in cosmetic procedures, to enhance or restore breast shape and volume. With advances in techniques and materials, these devices have become safer and more effective over the years. Nevertheless, complications such as capsular contracture, rupture, infections, or other types of malignancies (BIA-SCC). This study evaluated the postmarketing safety and performance of implants via technovigilance data and a review of scientific studies. Methods: The research analyzed publications from the BVS, PubMed, Embase, and ClinicalTrials databases from between 2007 and 2023 (15 years), in addition to reports registered in the Notivisa system during the same period. Results: A total of 113 studies were identified, 15 of which were selected for the final analysis, which revealed that capsular contracture, seroma, infection, and rupture were the most common complications. In the Notivisa system, 786 reports were found, including 397 technical complaints and 389 adverse events, with pain, infections, and lymphoma among the most frequently reported issues. Conclusions: These findings highlight the importance of continuous surveillance to identify risks and promote improvements in the quality and safety of breast implants, ensuring patient well-being. As a practical contribution, a clinical decision-making algorithm was proposed to support healthcare professionals in the early identification and management of implant-related complications.